COMP <GO>
PHR vs TSLA // EV/EBITDA & P/E VALUATION
Phreesia Inc. (NYSE) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: PHR 4
— TSLA 5
■ METRIC PARITY
LAST: $12.53 (+1.29%) • MKT CAP: $777.7M
valuation
—
LAST: $403.30 (-0.23%) • MKT CAP: $1.59T
valuation
199.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PHR VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PHR | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 19.29% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.00% | 3.39% | -5.39 | TSLA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 199.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.71% | 0.21% | +8.50 | PHR | /fcf-yield <GO> |
| Operating Margin | -1.40% | 3.35% | -4.75 | TSLA | /operating-margins <GO> |
| Net Profit Margin | 0.50% | 3.11% | -2.61 | TSLA | /net-margins <GO> |
| Revenue Growth (YoY) | 14.00% | 8.30% | +5.70 | PHR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.59 | 15.35 | -14.76 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | PHR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 8.72% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.0 | 56.6 | +10.38 | PHR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.89 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $777.7M | $1.59T | -$1.59T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PHR REV | TSLA REV | PHR GROSS % | TSLA GROSS % | PHR FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $467.8M | $94.83B | — | 18.0% | $67.7M | $6.22B |
| FY 2024 | $410.5M | $97.69B | — | 17.9% | $23.7M | $3.58B |
| FY 2023 | $346.0M | $96.77B | — | 18.3% | -$32.4M | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PHR // BETA —
TSLA // BETA 1.89